Why Exact Sciences Is Sinking and Genomic Health Is Rising

In response to a surprise merger agreement, shares of Exact Sciences (NASDAQ: EXAS) and Genomic Health (NASDAQ: GHDX) are on the move today. Exact Sciences' stock is down 12% as of 11:15 a.m. EDT while Genomic Health's is up about 2%.

Both cancer diagnostics companies have announced their intention to join forces to create a "best-in-class commercial, research, development and clinical organization."

Here are the key details of the transaction:

Continue reading

Quelle Fool.com